Report #2832758

Overview

Sex

Male

Age

Age unknown

State

NJ

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Inappropriate Schedule of Vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2020). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Inappropriate Schedule of Vaccine). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 17-MAR-2025 Pharmacy Student requested data regarding patient who received 1st Shingrix vaccine in 2020 (date unknown), 2nd dose in 2023 (date unknown). The reporter asked if the patient needs to receive a 3rd dose to complete series or it the 2 Shingrix vaccines was a complete series. The reporter consented to follow up. The patient received 2nd dose of Shingrix later than the recommended schedule, which led to lengthening of vaccination schedule.